Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03835299
Other study ID # NYBC 1243761
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 15, 2019
Est. completion date January 15, 2020

Study information

Verified date September 2021
Source Ohio University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, high school donors will be asked about their blood donation-related fears prior to their donation. Half of the donors reporting fear will be assigned to a brief coping skills intervention.


Description:

In this study the investigators will ask high school donors about their blood donation-related fears prior to their donation. Among those who report donation fear, half will be randomly assigned to receive a brief presentation of coping strategies administered via a computer tablet. The investigators will compare reaction rates and return behavior for the donors and high school drives where the study was conducted to the reaction and retention rates from similar blood drives where no data was collected. The investigators will also examine whether asking about the specific types of fear improves the prediction of syncopal or presyncopal reactions beyond the predictive value of a single fear question. Finally, the investigators will examine whether providing coping information to help manage the fear improves syncopal reaction rates and/or donor retention rates among fearful donors.


Recruitment information / eligibility

Status Completed
Enrollment 4035
Est. completion date January 15, 2020
Est. primary completion date January 15, 2020
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - To be eligible for inclusion in this study, the individual must have presented to donate blood at a New York Blood Center high school blood drive where data is being collected and have passed the health screening process. Exclusion Criteria: - Less than 16 years of age; inability to read and comprehend English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Fear Intervention
Coping information related to the fear that was identified by the participant will be presented via a computer tablet.

Locations

Country Name City State
United States Ohio University Athens Ohio

Sponsors (2)

Lead Sponsor Collaborator
Ohio University New York Blood Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Repeat Blood Donation Attempts Donor records will be used to track subsequent donation attempts during the follow-up. two years post-donation
Secondary Blood Donation Confidence Confidence in ability to cope with any donation-related fear immediately pre-donation
Secondary Vasovagal Reactions to Blood Donation phlebotomist ratings of blood donor vasovagal reactions immediately post-donation
See also
  Status Clinical Trial Phase
Completed NCT00097006 - Retrovirus Epidemiology Donor Study-II (REDS-II) N/A
Completed NCT00005721 - Retaining Donors and Increasing Donation Frequency N/A
Recruiting NCT04078893 - The Effect of Recruiting Inactive Blood Donors Using Different Means N/A
Completed NCT02274064 - Motivating Type O- Blood Donors to Return N/A
Completed NCT04783077 - Community-Based Communication Approaches for Blood Donation in Ghana N/A
Completed NCT02717338 - Blood Donor Competence, Autonomy and Relatedness Enhancement Phase 3
Completed NCT01104740 - Dengue Seroprevalence Study in Blood Donors in the French West Indies
Completed NCT03988738 - Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank N/A
Completed NCT04088695 - Effect of a Web Page Based on a Motivational Video for Voluntary Blood Donation N/A
Completed NCT00005278 - Retrovirus Epidemiology Donor Study I (REDS I) N/A
Recruiting NCT00001846 - Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Completed NCT00005339 - Risk of Post Transfusion Hepatitis C Virus Infection N/A
Terminated NCT00005341 - Blood Donation--Immune Sequelae and Recruitment
Recruiting NCT06021925 - Obstetrical History and Anti-HLA Antibodies Level
Completed NCT00005360 - HIV Diversity and Pathogenesis in Donor-Recipient Clusters N/A
Completed NCT03102385 - A Survey of Attitudes of Experienced Blood Donors N/A
Completed NCT02145507 - Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution Phase 1
Completed NCT00029406 - Transfusion Infections Pediatric Prospective Study (TRIPPS) N/A
Completed NCT00006310 - KSHV Infection in Blood Donors From Texas N/A